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Abstract
ZIKV was first identified in the 1940s as a mosquito-borne virus; however, 
sexual transmission, which is uncommon for arboviruses, was demonstrated 
more than 60 years later. Tissue culture and animal models have allowed scientists 
to study how this transmission is possible. Immunocompromised mice infected 
with ZIKV had high viral loads in their testes, and infection of immunocompetent 
female mice was achieved following intravaginal inoculation or inoculation via 
mating with an infected male. These mouse studies lead researchers to investigate 
the individual components of the male reproductive system. In cell culture and 
mouse models, ZIKV can persist in Sertoli and germ cells of the testes and epithelial 
cells in the epididymis, which may lead to sexual transmission even after ZIKV has 
been cleared from other tissues. ZIKV has also been studied in nonhuman primates 
(NHPs), which appears to mimic the limited human epidemiological data, with low 
rates of symptomatic individuals and similar clinical signs. Although refinement is 
needed, these animal models have proven to be key in ZIKV research and continue 
to help uncovering the mechanisms of sexual transmission. This review will focus 
on the animal models used to elucidate the mechanisms of sexual transmission and 
persistence of flaviviruses.
Keywords: Zika virus, sexual transmission, animal models, human, primate, mouse, 
Sertoli cell, testes
1. Introduction
Zika virus (ZIKV) is a single-stranded, positive-sense virus of the genus 
Flavivirus of the family Flaviviridae that was discovered in the Ziika forest of 
Uganda in 1947 [1]. The virus was isolated during a surveillance campaign to 
attempt to identify yellow fever virus in the region. Sentinel rhesus macaques were 
placed in cages in the canopy layer of the trees and monitored daily for spikes in 
temperature. One of the rhesus macaques became febrile and was bled to isolate the 
causative agent of the fever. Serum from clarified blood caused illness when injected 
intra-cranially in white mice and the brain homogenates from these animals 
contained the first isolate of ZIKV, MR766. It is noteworthy that this strain, which 
is used in many contemporaneous studies, was passaged over 100 times in mice to 
increase its virulence in rodents. A second strain, ZIKV 758, was made from another 
rhesus macaque injected with homogenates of Aedes africanus mosquitoes collected 
in that same area. These data demonstrate that ZIKV caused febrile disease in NHPs 
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and could be isolated from mosquitoes, solidifying it as an arbovirus [1]. In the 
years since, many additional isolates have been made and the ones discussed in this 
review are listed in Table 1.
Prior to the major outbreaks in the 2000s, ZIKV had not been detected in the 
Americas and reported human cases of ZIKV-caused disease were scarce world-
wide. Seroprevalence studies in Asia and Africa revealed human populations were 
exposed to the virus but disease was rarely reported, likely due to a high percentage 
of asymptomatic infection or because the signs and symptoms were indistinguish-
able from other known diseases [2]. Data collected during recent outbreaks in 
Yap Island and across the Americas revealed ZIKV is usually asymptomatic, with 
symptomatic cases being characterized by flu-like symptoms including self-limiting 
fever, headache, rash, and myalgia [3].
Worldwide outbreaks in Gabon, Micronesia and French Polynesia expanded the 
virus’ known range and susceptible population, allowing prospective epidemio-
logical studies. ZIKV likely arrived in the Americas in 2014, and in 2015 it quickly 
spread, starting its largest outbreaks to date [4, 5]. The large number of infected 
patients and heightened medical and scientific response allowed rare outcomes 
and transmission routes to be noticed. It was possible to identify that ZIKV causes 
congenital malformations [6]. Prior to this, cases of miscarriage, microcephaly and 
other congenital malformations, such as microcephaly or damage to brain and eye 
tissues, had been identified and were retrospectively observed to be correlated with 
infection [7, 8]. Infected travelers returning home initiated small traveler-associated 
transmission cycles, some of which were between sexual partners. Sexual transmis-
sion was proposed by Foy and colleagues, who described a probable case of ZIKV 
sexual transmission of a scientist that visited Senegal in 2008 [9]. Many more cases 
of sexual transmission were reported after the outbreaks in the Americas, confirm-
ing that sexual transmission played a role in the spread of ZIKV, although the full 
impact of sexual transmission may be underappreciated since it occurs concomi-
tantly with the more efficient transmission by mosquito vectors [10–13].
ZIKV or viral RNA was found to persist in human semen, vaginal secretions 
and blood [14, 15]. Acquiring samples to study viral persistence in these tissues is 
difficult because ZIKV infection is frequently asymptomatic and identification of 
ZIKV-positive samples has to be done by serology or molecular biology, since other 
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ZIKV. In Brazil, for example, there are several other flaviviruses and alphaviruses 
in circulation which produce clinical pictures that cannot be readily differentiated 
from the signs and symptoms associated with ZIKV. Therefore, molecular and sero-
logical tools are critical for the identification and classification of such samples [16]. 
In many locations, this requires a concerted collaborative effort between hospitals 
and laboratories, and many samples may need to be shipped before determining 
which patients came in contact with ZIKV. Additionally, sample collection is made 
difficult because once symptoms have rescinded, sample collections can no longer 
be made by hospitals and people may be opposed to having samples collected from 
them when they are no longer in need of medical care. In spite of these obstacles, 
several studies were able to assess ZIKV persistence in human samples. In semen, 
ZIKV RNA was detected for up to 6 months and ZIKV infectious particles could 
be isolated up to 1 month after primary infection [17]. Vaginal secretions were also 
found to be positive for RNA for up to 6 months after onset of symptoms [18]. These 
observations suggest sexual transmission could potentially happen even long after 
resolution of primary infection. Caution must be taken when trying to directly 
interpret the consequences of persistent viral RNA since this does not directly imply 
infectious viral particles. Regardless, transmission is possible, as demonstrated by a 
woman infecting her partner 44 days after onset of symptoms [13]. Although sexual 
transmission has most often been reported from males to females, there have been 
reports of suspected male-to-female [19], male-to-male [20] and female-to-male 
[21] transmissions. The actual rate of sexual transmission remains unknown.
Our current knowledge of the potential for sexual transmission among members 
of the Flavivirus genus is scarce but it appears that ZIKV is unique among this 
genus since most members are transmitted between hematophagous arthropods 
and vertebrate hosts. Although there is limited evidence that other flaviviruses 
could be sexually transmitted and persist in semen, the currently available body 
of data does not support this mode of transmission as significant for the spread of 
these viruses. West Nile virus (WNV) was proposed to have been possibly sexually 
transmitted in a clinical study of a woman who developed meningo-encephalitis by 
WNV 2 weeks after intercourse with an infected individual [22]. Other medically 
important flaviviruses, dengue virus (DENV) [23] and yellow fever virus (YFV) 
[24], have both been detected in human semen. DENV RNA was detected in a man 
returning from Thailand to Italy at 37 days post onset of symptoms, when virus 
RNA was not detectable in the serum or urine anymore [23]. Detection of DENV 
RNA in the seminal fluid is nevertheless not commonly reported, and another study 
that performed PCR in the semen of five man with acute DENV infection failed to 
detect any viral RNA [25]. YFV RNA was detected in urine and semen, but not in 
the serum, and the virus was isolated from urine on day 21 post onset the symp-
toms [24]. Another flavivirus, Japanese encephalitis virus (JEV), can be naturally 
found in porcine semen [26]. JEV was isolated from aborted fetus and semen of 
pigs which were naturally infected in China from 2004 to 2009 [27]. This raises 
the question of whether JEV also has the potential to reside in human testes and 
semen. Experimental approaches have also been used to determine the potential of 
flaviviruses to be sexually transmitted. Spondweni virus, a close relative to ZIKV, 
was detected in semen of mice lacking types I and III interferon (AG129) that were 
inoculated subcutaneously, although this was a rare occurrence when compared to 
ZIKV-infected AG129 mice [28]. Despite these clinical and experimental reports, 
the extent of the contribution of sexual transmission to the spread and maintenance 
of ZIKV in the human population remains unknown.
Examples of sexual transmission may be more common in the family Flaviviridae 
than in the genus Flavivirus, as exemplified by bovine viral diarrhea virus (pestivi-
rus, BVDV) in cattle and hepatitis C virus (hepacivirus, HCV) in humans. Both of 
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these infections can cause persistent infections in their hosts under certain condi-
tions and can be sexually transmitted. For BVDV, persistent infection was found 
in the testes, and bulls persistently shed viral particles in the seminal fluid which 
allows for sexual transmission [29–31]. For HCV, sexual transmission has been 
well-documented [32–35]; however, transmission is relatively inefficient [36] and 
increases with the number of partners, among human immunodeficient virus-
positive (HIV+) individuals or among men who have sex with other men [37, 38]. 
Although there are similarities between ZIKV and these two viruses, caution must 
be exercised when drawing comparisons, especially when looking for viral deter-
minants of persistence since there are multiple and substantial genomic differences 
between flaviviruses, pestiviruses and hepaciviruses.
The fact that ZIKV was shown to be sexually transmitted raised many ques-
tions, as many aspects of this mode of transmission are poorly understood for 
these viruses. Namely, the importance of sexual transmission for ZIKV in different 
regions of the world, the role of cells of the reproductive tract involved in ZIKV 
persistence and transmission, mutations in the virus which favor successful sexual 
transmission, interactions of ZIKV with the immune system in the reproductive 
tract and molecular interactions between ZIKV and host cells allowing for sexual 
transmission to take place, are all critical points of study. Although abundant data 
on human disease was generated during the recent outbreaks, animal experiments 
are an important tool to answer these questions because they allow controlled and 
rationally designed experiments which could ultimately lead to the development 
of new vaccines, therapeutics and prophylactic measures. This review will focus on 
what is currently known for ZIKV infection in the male reproductive tract.
2. Animal models of sexual transmission
Upon discovery of ZIKV, animal experiments were first conducted by Dick 
[39]. They found that white mice younger than 2 weeks were susceptible to ZIKV 
infections via intraperitoneal route, whereas mice older than 2 weeks were only 
susceptible to intracerebral inoculations [39]. Non-human primates inoculated sub-
cutaneously developed neutralizing antibodies against ZIKV and only one animal 
presented a slight elevation in temperature [39, 40]. Several decades after this initial 
study, several other model species were used as animal models for ZIKV, but efforts 
were mostly focused on mice [41–43] and non-human primates (NHPs) [44–47], 
with most studies being conducted after the outbreak in the Americas in 2015–2016. 
The experimental design and analyses should carefully consider the anatomical and 
physiological differences from the species used to humans as well as confounding 
factors such as different viral strains and inoculation titer and route.
2.1 Mouse models
Mouse models of sexual transmission for ZIKV initially utilized either interferon 
receptor deficient mice lacking type I (A129) [41] and or type I and II (AG129) 
interferon receptors [42]. Other models included interferon responsive mouse 
strains for which a transient knock-down of interferon response was induced by 
exogenous treatment with antibody against murine type I interferon receptor of 
wild-type mice or Rag1−/− mice (lacking both B and T lymphocytes) [48]. Several of 
these models have demonstrated sexual transmission from needle-inoculated male 
mice to naive female mice following mating. These studies, coupled with the use of 
surrogate breeding females from which uteri were gavaged, allowed direct assess-
ment of virus and viral RNA shedding efficiency over time. AG129 males infected 
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with ZIKV strain PRVABC59 were shown to shed infectious virus from 7 to 21 days 
post infection (dpi). Vasectomized males also were shown to shed virus; however, 
the magnitude was shown to be significantly lower compared to non-vasectomized 
males [42]. This finding was consistent with a previous study reporting ZIKV RNA 
shedding in symptomatic men infected with ZIKV in which vasectomized men shed 
significantly lower levels of ZIKV RNA [17].
The necessity for the use of mice lacking the ability to respond to interferon is 
due to the inherent resistance of murine STAT2 from being inhibited by ZIKV NS5 
[49]. In contrast, human STAT2 has been demonstrated to be highly susceptible to 
antagonism by ZIKV NS5 [50]. As such, the subsequent development of humanized 
STAT2 mice have proven useful as a fully interferon responsive model for which 
ZIKV can replicate and induce pathogenic responses [51].
2.1.1 Sexual transmission murine models
A number of different models have been developed in order to directly assess 
sexual transmission Sexual transmission has been modeled via direct intravaginal 
inoculation. In one model, AG129 male mice euthanized and caudal epididymal 
lumen (containing sperm) was collected. This suspension was used to inoculate 
female AG129 mice. In this study, the antioxidant ebselen was used to alleviate 
testicular pathology caused by ZIKV. Although intravaginally inoculated female 
AG129 mice with sperm from male mice treated with ebselen demonstrated reduced 
mortality, sexual transmission was not prevented, as female organs (ovary/fallopian 
tubes, spleen and brain) were infected [52]. Other studies have used homogenized 
accessory gland fluid and epididymal lumen fluid from Ifnar1−/− male mice subcuta-
neously inoculated with PRVABC59 to intravaginally inoculated female AG129 mice. 
In this study, females became viremic and succumbed to infection. Furthermore, 
progesterone pre-treatment of female mice before intravaginal inoculation was 
shown to increase mortality of females [53]. IFNAR1−/− male mice inoculated 
subcutaneously with PRVABC59 and then at 14 dpi or 35 dpi, prostatic and seminal 
vesicular homogenates and epididymal flushes were collected. Female AG129 mice 
inoculated intravaginally with this insemination fluid failed to become viremic [54].
Intravaginal inoculation of di-estrus timed AG129 mice or LysMCre+IFNARfl/fl 
mice (lacking IFNAR in myeloid cells) was shown to result in viremia and virus rep-
lication in peripheral organs and in the vaginal tissues measured by viral assay by 
RT-PCR through 10 dpi [55]. In an alternative study, immunocompetent C57BL/6 N 
female mice intravaginally inoculated with PRVABC59 showed a slight increase in 
viral RNA in the lower female reproductive tract (LFRT) from dpi 1 to 2 and mRNA 
expression of type I and III IFNs, IRF3/7, RIG-I, and MDA-5 was comparable to 
uninfected controls, suggesting that a dampened antiviral immune response occurs 
in the LFRT in response to infection with ZIKV. When mice were treated with an 
enhancer of RIG-1 signaling, the increase in ZIKV RNA in LFRT was not observed 
[56]. After intravaginal inoculation during the diestrus phase, ZIKV was shown to 
replicate in vaginal mucosa of wild type (WT) C57BL/6 and Ifnar1−/− mice. Fetuses 
from pregnant WT C57BL/6 mice developed intrauterine growth restriction and 
fetal brains were infected following intravaginal ZIKV inoculation. Fetuses from 
pregnant IFNAR1−/− mice developed severe intrauterine growth restriction and fetal 
death was observed. The pregnant females were found to develop viremia. These 
data are suggestive of an ascending infection from the vaginal tissues to the uterus 
for fetal involvement [57].
In addition to sexual transmission models that have utilized intravaginal 
exposure to model sexual transmission potential, several studies have addressed 
transmission dynamics through direct coitus models. AG129 males were found to 
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sexually transmit to naïve AG129 females in 50% of all matings as measured by 
subsequent viremias in mated females. This initial study demonstrated in utero 
infection after sexual transmission [42]. A subsequent study compared sexual 
transmission with subcutaneous and intravaginal routes on female disease presen-
tation, tropism and fetal infection. Sexual transmission of ZIKV to naïve female 
AG129 mice increased morbidity and mortality in these females as compared to 
female mice subcutaneously or intravaginally inoculated. Fetuses from females 
infected via sexual transmission had higher ZIKV titers compared to fetuses from 
pregnant females infected subcutaneously or intravaginally [58].
2.1.2  Potential sources of sexually transmitted virus/ZIKV infection of the murine 
testes and epididymides
The majority of ZIKV detected in the seminal fluid of infected AG129 mice dur-
ing the peak timing of sexual transmission (10–12 dpi) was from the supernatant 
fraction, suggesting cell-free ZIKV may be largely responsible for sexual transmis-
sion. In this study, the testes and epididymides were determined to be infected 
concurrently and epididymal epithelial cells were identified as the predominant 
cell population infected in epididymides and shown to contain replicating ZIKV 
by in situ hybridization. In the testes, interstitial leukocytes and peritubular myoid 
cells were found to be infected initially, followed by extensive infection of all layers 
of the seminiferous tubule epithelium [59]. Similar results were also shown in 
IFNAR1−/− mice for which epithelial components of epididymides were identified 
to be infected and that testes and epididymides could be infected concurrently [60]. 
In another experiment with immune competent C57BL/6 mice treated with anti-
IFNAR1 blocking antibody and subcutaneously inoculated with Asian and African 
genotype ZIKVs, sexual transmission potential was observed for all viruses with 
infectious virus identified in the epididymides from all groups even when infectious 
virus was absent from the testes and seminal vesicles. Infection of the epididymides 
was demonstrated to be critical for establishing sexual transmission potential, as 
infectious virus and viral RNA was detected in the epididymides and in semen days 
before infectious virus was detected in the seminal vesicles or testes [61].
Tissue restricted ZIKVs generated through the incorporation of microRNA 
target sequences within recombinant ZIKVs were utilized to assess the importance 
of different cell populations for sexual transmission potential. Testes-restricted 
ZIKVs could still infect the epididymides, demonstrating a hematogenous/
lymphogenous route of infection. Epididymides-restricted ZIKV had high titers 
in epididymides by plaque assay, but immunohistochemical analysis confirmed 
epididymides-restricted ZIKV did not replicate in the epididymal epithelium, sug-
gesting that ZIKV is transported from testes to epididymides via excurrent ducts 
in a cell-free form or transported in sloughed spermatids/infected luminal leuko-
cytes, and ZIKV can infect the epididymides via hematogenous/lymphogenous 
route of infection [62].
2.1.3 Persistence and tropism of ZIKV on the male reproductive tract
Tropism and persistence of ZIKV in the male reproductive tract may be the 
key factor responsible for the presence of the virus in semen even long after initial 
infection. A model of the male mouse reproductive tract is shown in Figure 1A. 
Based on in vivo studies, ZIKV is thought to infect the testes, an immunologically 
privileged site, via a hematogenous route [62] and by infecting the Sertoli cells 
(SC, Figure 1B), an important cell population responsible for the formation of the 
blood-testes barrier, as shown using AG129 mouse models [63, 64]. SC are critical 
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for spermatogenesis, since they nourish germ cells and help them mature. Tight 
junctions formed by adjacent SC are functional components of the blood-testes 
barrier (Figure 1C), which prevents molecules from passing between the blood 
and the lumen of a seminiferous tubule. From the testes, ZIKV can then reach the 
epididymides by the excurrent testicular route either by infecting germ cells or as 
free virus particles [62]. ZIKV can also infect the epididymides directly from the 
hematogenous route [62] (Figure 1), and infection of epididymides was observed 
to happen concurrently with testes infection, indicating that epididymal infec-
tion could happen directly and through the testes, or independently of the testes. 
Infection of germ cells in the testes is not a requirement for sexual transmission as 
there are reported cases of ZIKV sexual transmission from vasectomized men [65] 
and in experiments with vasectomized AG129s [42]. Instead, AG129 mouse models 
indicate that infection of epididymal epithelial cells may the major factor leading 
to shedding of virus particles in the semen, with these cells being the predominant 
source of cell-free ZIKV in the seminal fluid [66].
Intracellular viral persistence is likely an important component for long-term 
sexual transmission. Although the cells that act as reservoirs of ZIKV in testes and 
the reproductive tract are unknown, possible reservoirs in the host are SC [67, 68] 
germ cells [69], Leydig cells [70] and epididymal epithelial cells [59, 62] which have 
been shown to support persistent infections of ZIKV (Figure 1). When primary 
SCs persistently infected with two strains of ZIKV (PRVABC59 or MR766) were 
monitored for a period of 6 weeks, it was found that 15% of the cells were still 
positive for both strains of ZIKV [67]. In this same study, Leydig cells were not 
observed to support persistence [67]. The mechanisms underlying persistence 
of ZIKV in testes are likely multifactorial and represent a complex phenomenon 
involving interactions between viral and host factors that needs to be studied in 
depth. The interactions that occur between ZIKV and host factors that are required 
for long-term infection of the testes/epididymides are poorly understood and viral 
persistence likely requires a balance between efficient viral replication and dam-
age caused to host cells. The AXL receptor tyrosine kinase, which was previously 
shown to be required for entry of ZIKV and other flaviviruses into certain cell 
types, has been shown to be required for ZIKV entry in SCs [71], but may also be 
involved in negatively regulating SCs innate immune response [72]. ZIKV infection 
of SCs results in gene expression changes, with upregulation of antiviral pathways, 
dysregulation of junction and growth pathways [67, 73]. Although the immune 
Figure 1. 
The male reproductive tract. (A) Overall representation of the male reproductive tract. (B) Seminiferous 
tubules. (C) Seminiferous tubules in detail.
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system of the reproductive tract in females is able to eventually clear ZIKV, largely 
due to interferon signaling [74, 75], such as the type III interferon lambda [76], 
the microenvironment of the male testes is an immune-privileged site that lacks 
adequate response for clearance [77].
2.1.4 Viral genetic changes associated with persistence
Mosquito-vectored flaviviruses that can result in persistent infections are usu-
ally associated with an accumulation of adaptive mutations, suggesting that viral 
genetics may also play an important role for establishing persistence. Examples of 
mutations in viruses causing persistence were shown with ZIKV, WNV [78–80], 
JEV [81], YFV [24, 82], and DENV [23]. These mutations happen in different viral 
proteins and appear to affect various viral functions, but in general attenuate the 
virus to cause less cytopathic effects, which is likely important for persistence. 
Identifying the mutations and cellular components that allow flaviviruses to cause 
long-term infections may elucidate mechanisms by which ZIKV is able to remain 
stable in seminal fluid long after infection. Although functional mutations in ZIKV 
may have been found in the male reproductive tract and ejaculates of mice [83], 
these were do not appear to be specific to these tissues as they were also found after 
passaging in Vero cells [83], and no mutation has been identified to be required for 
persistence and/or sexual transmission. Continuing research efforts using animal 
models are paramount to understand the mechanisms of ZIKV persistence, sexual 
transmission, reservoirs and interactions with cellular targets.
2.2 Non-human primate (NHP) models
NHP models are also frequently used to study ZIKV since their biology more 
closely relates to a human than does mouse biology. Several non-human primates 
were shown to be susceptible to ZIKV and used to study pathogenesis and infection 
of the reproductive tract, including cynomolgus macaques (Macaca fascicularis), 
rhesus macaques (Macaca mulatta), pigtail macaques (Macaca nemestrina) and 
olive baboon (Papio anubis), as well as neotropical non-human primates of the 
Callithrix, Saimiri and Aotus genera [46, 84]. These species presented viremia and 
variable degrees of clinical signs following ZIKV infection. Although many stud-
ies were conducted looking at ZIKV pathogenesis and the effects of infection on 
reproductive tissues, studies directly testing sexual transmission are lacking due 
to technical and logistical difficulties. Instead, vaginal or rectal inoculations have 
been used to simulate a sexual transmission. These and other insights into sexual 
transmission of non-human primates can also shed light on whether this type of 
transmission play a role in maintenance of ZIKV in nature, since primates are puta-
tive ZIKV reservoirs.
Because NHPs are evolutionarily close to humans, it is not surprising that these 
animals and their reproductive tract are anatomically and physiologically more 
similar to humans than other models such as mice; thus, NHPs are often considered 
to be one of the most relevant animal models [85, 86]. Unlike mice, immunocompe-
tent NHPs are more suitable to study ZIKV infections, although the extent to which 
disease is mimicked is difficult to assess and varies with NHP species. Most NHP 
models were similar to humans in that most infections were asymptomatic, with 
clinical signs observed in some individuals [87, 88]. Considering that many human 
infections are asymptomatic, it is currently unclear if the clinical signs displayed by 
NHPs are a good model for disease rate and severity in humans. In a study using four 
cynomolgus macaques one individual was shown to present reduced body tempera-
ture [87]. Studying ZIKV pathogenesis in NHPs is important to understand disease 
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progression, clinical signs, negative effects to the reproductive tract and outcomes 
of pregnancy. These data also inform the design of sexual transmission studies as 
far as titers, timepoints and strain used for infection, tissues that are important for 
disease and persistence so sexual transmission can take place. It is worth noting that 
these experimental infections are performed using virus in a needle while most [89] 
natural infections occur by a mosquito bite; mosquito saliva has immunomodula-
tory properties that have been shown to enhance disease in other flaviviral infection 
[90–92] and could be another confounding factor in these studies.
2.2.1 Cynomolgus macaque
Cynomolgus macaques were shown to be suitable as models for ZIKV pathogenesis 
and sexual transmission [87, 88, 93]. Infection with 5 log10 of plaque forming units 
(PFU) of ZIKV from various geographical origins resulted in viremia which peaked at 
2-4 dpi at 4-7 log10 ZIKV genome copies/ml [87, 88]. The outbreak strain PRVABC59 
was more virulent than the Asian FSS13025 and the African IBH30656 ZIKV, with 
the animals infected with the PRVABC59 strain being viremic for extended periods 
of time. Bodily fluids checked did not include seminal fluid, and shedding of virus 
in the urine and saliva was not observed with either the FSS13025 [87] or IBH30656 
strains. ZIKV FSS13025 was detected in testes [88], consistent with murine infections 
with this strain [41]. On the other hand, ZIKV PRVABC59 was detected in urine, 
saliva and testes [88]. The fact that virus was found in testes suggests this species of 
NHP could model virus persistence in testes well and may also be a positive feature of 
this model for sexual transmission in general. The cynomolgus macaque model has 
also been shown to likely support sexual transmission, as macaques inoculated with 
7 log10 PFU of virus intravaginally and intrarectally became viremic 50% and 100% 
of the time, respectively [93]. To understand the implications of these findings would 
be important to know the ranges of ZIKV titers in the semen. Although it is not clear 
what the viral titers are in most human semen samples, studies detected up to 9 log10 
RNA copies/ml of virus in semen of patients [17, 89].
2.2.2 Olive baboon
As with cynomolgus macaques, infection of olive baboons with different strains 
of ZIKV did not result in overt clinical signs. Following subcutaneous inoculation of 
a French Polynesian ZIKV (H/PF/2013), the baboons presented viremia that peaked 
at 3 and 4 dpi [45]. Around 40 days post infection, tissues were collected and virus 
was found in lymph nodes and epididymides, suggesting these are the places where 
the virus can persist even after viral clearance from the blood [45]. This suggests the 
testes were likely infected at some point and that the epididymides may also play a 
role in virus persistence [45]. Olive baboons were also used to model ZIKV infec-
tion during pregnancy. Infection of 4 log10 of ZIKV H/PF/2013 resulted in vertical 
transmission in 3 out of 4 pregnant NHPs [94]. Unlike the non-pregnant animals, 
all dams presented rash and conjunctivitis [94]. Fetal death and defects in the 
frontal cortex of the fetus were observed [94].
2.2.3 Rhesus macaque
The rhesus macaque is perhaps the most utilized NHP model to study ZIKV 
infection. Many studies of ZIKV were done using this species, including pathogen-
esis analyses in pregnant and non-pregnant animals, immunological and serologi-
cal studies, and testing of anti-ZIKV vaccines or drugs [44, 95–106]. A study in 
which ZIKV was inoculated intravaginally in rhesus macaques to mimic sexual 
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transmission found ZIKV RNA in the reproductive tract of all 6 animals infected, 
thus raising the question of whether fetal disease could be more pronounced after 
sexual transmission when compared to vectored transmission [103]. This study 
lacked subcutaneous inoculation controls and further studies need to be conducted 
to confirm these findings. Another study comparing the intravaginal and subcu-
taneous routes using ZIKV PRVABC59 found peak viremia at 5–8 dpi that were 
variable in titer (3–7.5 log10 PFUs). Although the types of tissue found to be positive 
differed between subcutaneous and intravaginal inoculated animals, there was no 
obvious preference for reproductive tract tissues in the intravaginal route [107]. 
The data showed that intravaginal infection resulted in less CD11Chi myeloid cells, 
reduced expression of programmed cell death protein 1 (PD-1) in natural killer cells 
(NK) and more Ki67+ CD8+ central memory cells, indicating the route of infection 
may play a role in shaping the immune response [107].
Persistent ZIKV in reproductive tissues may play a role in sexual transmission 
long after primary infection. After intravenous inoculation of 5 log10 of a Brazilian 
ZIKV (BeH815744) in female rhesus macaques, ZIKV RNA was detected in multiple 
tissues of the NHPs, including reproductive tissues 14 dpi [108]. Lymphoid tissues 
had the highest detectable amount of viral RNA, suggesting these organs, which 
span many parts of the body, may act as possible viral reservoir [108].
2.3 Other animal models
Several other animal models have been used to study ZIKV but most are not 
focused on sexual transmission. These models include guinea pigs [109–111], ham-
sters [112], bats [113], chick embryos, piglets [114, 115] and boars [116]. Porcine 
fetuses were shown to present mild to severe neuropathology upon ZIKV infection 
[114, 115]. Boar semen was inoculated with ZIKV, but it was concluded that ZIKV 
does not appear to cause cell damage and cannot replicate efficiently or persist in 
the semen of this species [116]. With respect to the neotropical chiropteran model, 
viral RNA was found in different tissues of fruit bats 28 dpi, suggesting ZIKV can 
infect bats which may serve as virus reservoirs. Bats did not show any signs of dis-
ease [113]. Stat-2 knockout hamsters infected with ZIKV have shown presence on 
infected cells with morphology of SCs and spermatogonia, suggesting this could 
be a suitable model to study persistence of the virus in testes [112]. The guinea pig 
models report conflicting results. One study with ZIKV challenge mid-gestation 
showed no evidence of infection [109]; however, Kumar et al. show guinea pigs 
inoculated subcutaneously with PRVABC59 had viremia and presented signs such 
as fever, hunched posture and detectable viral RNA in the blood [110]. Deng et al. 
showed that intranasally-infected guinea pigs have virus in the sera, saliva and 
tears [111].
3. Conclusions
ZIKV has emerged explosively since 2007, causing an epidemic in the Americas 
in 2015/16 and become a matter of global health importance. Although data from 
epidemiologic analyses and case studies helped shed light on the diseases caused by 
ZIKV, animal models will be important to substantiate and extend these findings 
under controlled experimental settings. Animal models can be—and have already 
proven to be—useful as a tool to understand ZIKV transmission and ZIKV-caused 
illnesses. Animal models do not fully recapitulate diseases as seen in humans; there-
fore, it is critical to consider the advantages and drawbacks of each model when 
designing and executing the experiments as well as interpreting the data. Models 
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to study sexual transmission are currently scarce and need further development. 
Challenges include scarcity of good models to study ZIKV sexual transmission, 
low number of animals used and the requirement to improve reproducibility of the 
findings from animal models, which is caused by differences in experimental condi-
tions and the number of animals used. As in certain cases increasing the number of 
animals used is not possible due to it being prohibitively expensive or posing ethical 
issues, future experiments assessing sexual transmission of ZIKV should focus on 
optimizing experimental design and analysis, when possible standardizing experi-
mental conditions so they can be compared between studies.
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